Literature DB >> 9759658

Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.

T Hara1, A Ooi, M Kobayashi, M Mai, K Yanagihara, I Nakanishi.   

Abstract

Gene amplifications of c-myc, K-sam, and c-met were examined in cancer nuclei isolated from 154 primary gastric adenocarcinomas by fluorescence in situ hybridization (FISH) using cosmid probes for 8q24 (c-myc locus) and 7q31 (c-met), as well as a DNA probe for K-sam synthesized by PCR. The results were compared with those of Southern blot analysis. Dual-color FISH using gene locus and chromosome-specific probes detected gene amplifications of c-myc in 24 tumors (15.5%), c-met in 6 tumors (3.9%), and K-sam in 3 tumors (2.9%). The six tumors with c-myc amplification had also been found to have amplified c-erbB-2 in our previous study, and coamplification of c-myc and c-met was found in two other tumors. This technique also differentiated the amplified genes on the homogeneous staining region (HSR) and on double minute chromosomes (DMs) in metaphase spreads and interphase nuclei of cell lines established from poorly differentiated adenocarcinomas, KATO III, SNU 16, and HSC 39. Examination of FISH images of these cell lines suggested that the high-level amplifications of c-myc found in primary tumors occurred mainly on DM in four tumors and on HSR in one, and those of K-sam occured on DM in two tumors and on HSR in one. No high-level amplification of c-met was found. These high-level amplifications were also detected in formalin-fixed, paraffin-embedded tissues from primary gastric tumors and metastatic lymph nodes, in some of which heterogeneity of gene amplification was demonstrated within the same tumor. We conclude that FISH is an important tool for examining the proto-oncogene aberrations in intact cells in solid tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759658

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  61 in total

1.  The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction.

Authors:  Sharon L Barrans; Paul A S Evans; Sheila J M O'Connor; Roger G Owen; Gareth J Morgan; Andrew S Jack
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

2.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

3.  Omission of breakfast and risk of gastric cancer in Mexico.

Authors:  Monserrat Verdalet-Olmedo; Clara Luz Sampieri; Jaime Morales-Romero; Hilda Montero-L de Guevara; Alvaro Manuel Machorro-Castaño; Kenneth León-Córdoba
Journal:  World J Gastrointest Oncol       Date:  2012-11-15

Review 4.  Current advances of targeting HGF/c-Met pathway in gastric cancer.

Authors:  Aristomenis Anestis; Ilianna Zoi; Michalis V Karamouzis
Journal:  Ann Transl Med       Date:  2018-06

Review 5.  MET overexpression and gene amplification in NSCLC: a clinical perspective.

Authors:  Lorenza Landi; Gabriele Minuti; Armida D'Incecco; Jessica Salvini; Federico Cappuzzo
Journal:  Lung Cancer (Auckl)       Date:  2013-06-18

6.  Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.

Authors:  Akishi Ooi; Takeru Oyama; Ritsuko Nakamura; Ryosuke Tajiri; Hiroko Ikeda; Sachio Fushida; Hiroyuki Nakamura; Yoh Dobashi
Journal:  Mod Pathol       Date:  2015-03-06       Impact factor: 7.842

Review 7.  MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy.

Authors:  Hisato Kawakami; Isamu Okamoto
Journal:  Gastric Cancer       Date:  2015-12-21       Impact factor: 7.370

8.  MET and MYC cooperate in mammary tumorigenesis.

Authors:  Alana L Welm; Suwon Kim; Bryan E Welm; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

9.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

10.  Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer.

Authors:  Tobias Ach; Katharina Zeitler; Stephan Schwarz-Furlan; Katharina Baader; Abbas Agaimy; Christian Rohrmeier; Johannes Zenk; Martin Gosau; Torsten E Reichert; Gero Brockhoff; Tobias Ettl
Journal:  Virchows Arch       Date:  2012-12-15       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.